imipenem

(redirected from Cilastatin)
Also found in: Medical, Wikipedia.
Translations

imipenem

n imipenem m
References in periodicals archive ?
* Merck announced FDA approval of RECARBRIO (imipenem, cilastatin, and relebactam) for the treatment of adults with complicated urinary tract and complicated intra-abdominal bacterial infections where limited or no alternative treatment options are available.
The US Food and Drug Administration (FDA) has granted approval to United States-based Merck for its Recarbrio (imipenem, cilastatin and relebactam) intended to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI), it was reported yesterday.
The US Food and Drug Administration (FDA) on Wednesday cleared the marketing of the antibacterial drug Recarbrio (imipenem, cilastatin and relebactam), for adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) under its Qualified Infectious Disease Product (QIDP) designation & Priority Review designations.
THURSDAY, July 18, 2019 (HealthDay News) -- The antibacterial drug product Recarbrio (imipenem, cilastatin, and relebactam) has been approved to treat complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults, the U.S.
WEDNESDAY, July 17, 2019 (HealthDay News) -- The antibacterial drug product Recarbrio (imipenem, cilastatin, and relebactam) has been approved to treat complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) in adults, the U.S.
Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.
Receptor activated protein (RAP) and cilastatin have been shown to block the reabsorption of these toxins through megalin-mediated endocytosis [21, 22].
With regard to the bacterial infection, the patient only received antimicrobial treatment with imipenem and cilastatin; infection associated with cocci, such as staphylococcus aureus and enterococcus, the most common causative organism, was not considered in the course of medical treatment.
He was given imipenem and cilastatin sodium, vancomycin, and caspofungin with reduced dose of corticosteroid.
They tested 12 of the most common types of antibiotics, finding that two combinations in particular - piperacillin and tazobactam, and imipenem and cilastatin - led to a higher risk of a life-threatening inflammatory condition called graft-versus-host disease (GVHD).
Comparison of efficacy of cefoperazone/sulbactam and imipenem/ cilastatin for treatment of Acinetobacter bacteremia.